dr. balar on mature clinical results of keynote-052 in urothelial cancer
Published 7 years ago • 281 plays • Length 1:57Download video MP4
Download video MP3
Similar videos
-
0:54
dr. balar on results of keynote-052 in urothelial cancer
-
0:47
dr. balar on combinations with pembrolizumab for urothelial cancer
-
1:37
dr. balar on next steps of the keynote-057 trial in nmibc
-
1:33
dr. balar on results of durvalumab plus tremelimumab in bladder cancer
-
0:48
dr. balar on the future of immunotherapy in bladder cancer
-
1:07
dr. balar discusses keynote-057 study in nmibc
-
1:08
dr. balar on pd-l1 testing for urothelial cancer
-
0:54
dr. balar on biomarkers of immunotherapy response in bladder cancer
-
0:51
dr. balar on the approval of pembrolizumab for bladder cancer
-
1:09
dr. balar on current and future standards of care in kidney cancer treatment
-
1:09
dr. balar on improved outlook in metastatic bladder cancer
-
1:25
dr. balar on imvigor 210 results for metastatic urothelial carcinoma
-
1:32
dr. balar discusses study of immunotherapy combination in bladder cancer
-
0:06
copy of dr. balar discusses the impact of immunotherapy on bladder cancer
-
1:52
dr. balar on immunotherapy treatment in bladder cancer
-
0:52
dr. balar discusses the impact of immunotherapy on bladder cancer
-
1:58
results for first-line pembrolizumab in advanced urothelial carcinoma
-
1:07
dr. balar on impact of durvalumab plus tremelimumab in bladder cancer
-
1:57
dr. balar on remaining questions with immunotherapy in bladder cancer